According to a new market report published by Lucintel, the future of the cell banking outsourcing market looks promising with opportunities in bank preparation, storage, characterization & testing, safety testing, viral, microbial banks, gene expression, karyology, and gene sequencing testing. The global cell banking outsourcing market is expected to grow with a CAGR of 16% from 2020 to 2025. The major drivers for this market are growing demand for gene therapy, stem cell therapy, biopharmaceutical production, and increasing prevalence of oncology associated diseases and other infectious chronic disorders.
To download report brochure, please go to https://www.lucintel.com/cell-banking-outsourcing-market.aspx and click "download brochure" tab from the menu
Cell banking outsourcing involves collection, storage, characterization, and testing of cells, cell lines, and tissues. In this market, master cell banking, working cell banking, and viral cell banking are the major bank types. Lucintel forecasts that master cell banking will remain the largest bank type segment over the forecast period due to longer duration of preservation of cells.
Within this market, stem cell banking will remain the largest cell type segment over the forecast period due to the increasing number of cord blood banks, immediate availability of blood cells can be provided in even rural areas, and lower risk of viral contamination.
North America will remain the largest region over the forecast period due to a large number of pharmaceutical and biotechnology companies in the region, the presence of a well-established healthcare market, and rising production of vaccines, therapeutic proteins, and antibiotics.
BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem, Goodwin Biotechnology, Lonza, and Texcell are among the major suppliers in the global cell banking outsourcing market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cell banking outsourcing market by bank type, cell type, phase, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Cell Banking Outsourcing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global cell banking outsourcing market by bank type, cell type, phase, and region as follows:
By Bank Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Master Cell Banking
Working Cell Banking
Viral Cell Banking
By Cell Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Stem Cell Banking
Cord Stem Cell Banking
Embryonic Stem Cell Banking
Adult Stem Cell Banking
Dental Stem Cell Banking
IPS Stem Cell Banking
Non-Stem Cell Banking
By Phase [Value ($ Million) shipment analysis for 2014 – 2025]:
Bank Preparation
Storage
Characterization & Testing
Safety Testing
Viral
Microbial Banks
Gene Expression
Karyology
Gene Sequencing Testing
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.